Submitted by Anonymous (not verified) on 29 September 2025 - 15:16
Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 26, Status: Authorised